Redeye is encouraged that Dignitana continues to grow even with the headwind in the markets. The cost control is also a positive, even if we do not expect the current low levels to be sustainable when markets become more normal. We have updated our market model and primarily adjusted our cost estimates in the short term. We see exciting times ahead with the reimbursement processes in the second half of 2021. We raise our Base case fair value to SEK 16 (15) per share.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Dignitana Q1’21 - Exciting Times Ahead

© Modular Finance, source Nordic Press Releases